2021 ESMO Congress 2021 AUA Annual Meeting 2021 AUA Annual Meeting: Prostate Cancer 2021 AUA meeting preview: prostate, bladder, and kidney cancer 2021 AUA meeting preview: BPH, stones, and incontinence Urology Times Journal Urologists in Cancer Care UroView Around the Practice

2021 ESMO Congress2021 AUA Annual Meeting 2021 AUA Annual Meeting: Prostate Cancer2021 AUA meeting preview: prostate, bladder, and kidney cancer2021 AUA meeting preview: BPH, stones, and incontinenceUrology Times JournalUrologists in Cancer CareUroViewAround the Practice

Clinical

View More Prostate Cancer Bladder Cancer Kidney Cancer BPH OAB and Incontinence Kidney Stones Sexual Dysfunction Hormone Therapy Next-Generation Imaging

Prostate CancerBladder CancerKidney CancerBPHOAB and IncontinenceKidney StonesSexual DysfunctionHormone TherapyNext-Generation Imaging

Business

View More Health Law & Policy Malpractice Consult Practice Management

Health Law & PolicyMalpractice ConsultPractice Management

News

Clinical

All Clinical Benign Conditions Bladder Cancer BPH Female Urology Genitourinary Cancers Hormone Therapy Kidney Cancer Kidney Stones Men's Health Next-Generation Imaging Pediatrics Prostate Cancer Sexual Dysfunction Urologic Surgery

All ClinicalBenign ConditionsBladder CancerBPHFemale UrologyGenitourinary CancersHormone TherapyKidney CancerKidney StonesMen's HealthNext-Generation ImagingPediatricsProstate CancerSexual DysfunctionUrologic Surgery

Media

Podcasts 'Y'tube UroView UTv Videos Around the Practice BPH Videos Medical World News Readout 360 Viewpoints

Podcasts'Y'tubeUroViewUTv VideosAround the PracticeBPH VideosMedical World NewsReadout 360Viewpoints

Conferences

Publications

Supplements and Featured Publications Urologists in Cancer Care Urology Times Journal

Supplements and Featured PublicationsUrologists in Cancer CareUrology Times Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Interactive Tools Job Board Partners Sponsored

Interactive ToolsJob BoardPartnersSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

Spotlight

2021 ESMO Congress
2021 AUA Annual Meeting
2021 AUA Annual Meeting: Prostate Cancer
2021 AUA meeting preview: prostate, bladder, and kidney cancer
2021 AUA meeting preview: BPH, stones, and incontinence
Urology Times Journal
Urologists in Cancer Care
UroView
Around the Practice

ClinicalSee All >

Prostate Cancer
Bladder Cancer
Kidney Cancer
BPH
OAB and Incontinence
Kidney Stones
Sexual Dysfunction
Hormone Therapy
Next-Generation Imaging

BusinessSee All >

Health Law & Policy
Malpractice Consult
Practice Management

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

New Products & Services

September 1, 2003

Raritan, NJ-Ortho-McNeil Pharmaceutical has received FDA approval to market levofloxacin (Levaquin) for the treatment of chronic bacterial prostatitis caused by Escherichia coli, Enterococcus faecalis, or Staphylococcus epidermidis.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria